Compare HSBC Holdings plc (HSBC) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HSBC Holdings plc vs GeneDx Holdings Corp — how do they compare? HSBC Holdings plc trades at $101.09 (market cap $335.21B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: HSBC Holdings plc is far larger — about 186.2× GeneDx Holdings Corp's market cap, and HSBC Holdings plc pays a 3.79% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| HSBC | WGS | |
|---|---|---|
Market Cap | $335.21B | $1.80B |
Sector | Technology | Technology |
52-Week High | $100.61 | $167.51 |
52-Week Low | $61.30 | $34.51 |
Dividend Yield | 3.79% | — |
Enterprise Value | — | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
